Oliver Smithies
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oliver Smithies has a total of 252 co-authors. Here are the top co-authors by number of shared publications:
Hyung-Suk Kim
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599
3 shared publicationsA. Almeida
1 shared publicationAdalberto Ibatici
1 shared publicationAdrian Woolf
1 shared publicationAkihiro Tojo
1 shared publication- Alessandra Dei Cas
Department of Endocrinology and Metabolic Diseases, Parma University Hospital, 43126 Parma, Italy
1 shared publication
Latest Publications
- 9 April 2012
- Published by Springer Nature
- Vol. 869, 1-21
How It All Began: A Personal History of Gel Electrophoresis
Arne Tiselius’ moving boundary electrophoresis method was still in general use in 1951 when this personal history begins, although zonal electrophoresis with a variety of supporting media (e.g., filter paper or starch grains) was beginning to replace it. This chapter is an account of 10 years of experiments carried out by the author during which molecular sieving gel electrophoresis was developed and common genetic variants of two proteins, haptoglobin and transferrin, were discovered in normal individuals. Most of the figures are images of pages from the author’s laboratory notebooks, which are still available, so that some of the excitement of the time and the humorous moments are perhaps apparent. Alkaline gels, acidic gels with and without denaturants, vertical gels, two-dimensional gels, and gels with differences in starch concentration are presented. The subtle details that can be discerned in these various gels played an indispensable role in determining the nature of the change in the haptoglobin gene (Hp) that leads to the polymeric series characteristic of Hp 2 /Hp 2 homozygotes. Where possible, the names of scientific friends who made this saga of gel electrophoresis so memorable and enjoyable are gratefully included.
- 9 April 2012
- Published by Springer Nature
- Vol. 869, 1-21
How It All Began: A Personal History of Gel Electrophoresis
Arne Tiselius’ moving boundary electrophoresis method was still in general use in 1951 when this personal history begins, although zonal electrophoresis with a variety of supporting media (e.g., filter paper or starch grains) was beginning to replace it. This chapter is an account of 10 years of experiments carried out by the author during which molecular sieving gel electrophoresis was developed and common genetic variants of two proteins, haptoglobin and transferrin, were discovered in normal individuals. Most of the figures are images of pages from the author’s laboratory notebooks, which are still available, so that some of the excitement of the time and the humorous moments are perhaps apparent. Alkaline gels, acidic gels with and without denaturants, vertical gels, two-dimensional gels, and gels with differences in starch concentration are presented. The subtle details that can be discerned in these various gels played an indispensable role in determining the nature of the change in the haptoglobin gene (Hp) that leads to the polymeric series characteristic of Hp 2 /Hp 2 homozygotes. Where possible, the names of scientific friends who made this saga of gel electrophoresis so memorable and enjoyable are gratefully included.
- 9 May 2011
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (21) , 8779-8784
Mitochondrial DNA polymerase editing mutation, Polg D257A , reduces the diabetic phenotype of Akita male mice by suppressing appetite
Diabetes and the development of its complications have been associated with mitochondrial DNA (mtDNA) dysfunction, but causal relationships remain undetermined. With the objective of testing whether increased mtDNA mutations exacerbate the diabetic phenotype, we have compared mice heterozygous for the Akita diabetogenic mutation (Akita) with mice homozygous for the D257A mutation in mitochondrial DNA polymerase gamma (Polg) or with mice having both mutations (Polg-Akita). The Polg-D257A protein is defective in proofreading and increases mtDNA mutations. At 3 mo of age, the Polg-Akita and Akita male mice were equally hyperglycemic. Unexpectedly, as the Polg-Akita males aged to 9 mo, their diabetic symptoms decreased. Thus, their hyperglycemia, hyperphagia and urine output declined significantly. The decrease in their food intake was accompanied by increased plasma leptin and decreased plasma ghrelin, while hypothalamic expression of the orexic gene, neuropeptide Y, was lower and expression of the anorexic gene, proopiomelanocortin, was higher. Testis function progressively worsened with age in the double mutants, and plasma testosterone levels in 9-mo-old Polg-Akita males were significantly reduced compared with Akita males. The hyperglycemia and hyperphagia returned in aged Polg-Akita males after testosterone administration. Hyperglycemia-associated distal tubular damage in the kidney also returned, and Polg-D257A-associated proximal tubular damage was enhanced. The mild diabetes of female Akita mice was not affected by the Polg-D257A mutation. We conclude that reduced diabetic symptoms of aging Polg-Akita males results from appetite suppression triggered by decreased testosterone associated with damage to the Leydig cells of the testis.
- 9 May 2011
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (21) , 8779-8784
Mitochondrial DNA polymerase editing mutation, Polg D257A , reduces the diabetic phenotype of Akita male mice by suppressing appetite
Diabetes and the development of its complications have been associated with mitochondrial DNA (mtDNA) dysfunction, but causal relationships remain undetermined. With the objective of testing whether increased mtDNA mutations exacerbate the diabetic phenotype, we have compared mice heterozygous for the Akita diabetogenic mutation (Akita) with mice homozygous for the D257A mutation in mitochondrial DNA polymerase gamma (Polg) or with mice having both mutations (Polg-Akita). The Polg-D257A protein is defective in proofreading and increases mtDNA mutations. At 3 mo of age, the Polg-Akita and Akita male mice were equally hyperglycemic. Unexpectedly, as the Polg-Akita males aged to 9 mo, their diabetic symptoms decreased. Thus, their hyperglycemia, hyperphagia and urine output declined significantly. The decrease in their food intake was accompanied by increased plasma leptin and decreased plasma ghrelin, while hypothalamic expression of the orexic gene, neuropeptide Y, was lower and expression of the anorexic gene, proopiomelanocortin, was higher. Testis function progressively worsened with age in the double mutants, and plasma testosterone levels in 9-mo-old Polg-Akita males were significantly reduced compared with Akita males. The hyperglycemia and hyperphagia returned in aged Polg-Akita males after testosterone administration. Hyperglycemia-associated distal tubular damage in the kidney also returned, and Polg-D257A-associated proximal tubular damage was enhanced. The mild diabetes of female Akita mice was not affected by the Polg-D257A mutation. We conclude that reduced diabetic symptoms of aging Polg-Akita males results from appetite suppression triggered by decreased testosterone associated with damage to the Leydig cells of the testis.
- 18 January 2011
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (5) , 2070-2075
A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy
Polymorphisms in the human endothelial nitric oxide synthase (eNOS) gene (NOS3) have been associated with advanced nephropathy in diabetic patients and with decreased expression in tissue culture. However, direct proof that modest genetic decreases in eNOS expression worsen diabetic nephropathy is lacking. To investigate this effect, we took advantage of the hybrid vigor and genetic uniformity of the F1 progeny (eNOS+/+, eNOS+/−, or eNOS−/− with or without diabetes) of a cross between heterozygous 129S6/SvEvTac eNOS+/− inbred females and heterozygous C57BL/6J eNOS+/− inbred males carrying the dominant Akita diabetogenic mutation Ins2C96Y/+. Whereas all C57BL/6J inbred eNOS−/− and eNOS+/− diabetic mice died before 5 mo, almost half of the F1 hybrid eNOS−/− and eNOS+/− diabetic mice lived until killed at 7 mo. Heterozygous eNOS+/− diabetic mice expressed ∼35% eNOS mRNA in the kidney and ∼25% glomerular eNOS protein relative to their eNOS+/+ diabetic littermates. These decreases in eNOS elevated blood pressure (BP) but not blood glucose. Urinary albumin excretion, mesangial expansion, glomerulosclerosis, mesangiolysis, and glomerular filtration rate increased in the order: eNOS+/+ Akita < eNOS+/− Akita < eNOS−/− Akita, independently of BP. Glomerular basement membrane thickening depended on increased BP. Renal expression of tissue factor and other inflammatory factors increased with the nephropathy; Nos2 also increased. Surprisingly, however, decreased eNOS expression ameliorated the increases in oxidative stress and tubulointerstitial fibrosis caused by diabetes. Our data demonstrate that a modest decrease in eNOS, comparable to that associated with human NOS3 variants, is sufficient to enhance diabetic nephropathy independently of its effects on BP.
- 18 January 2011
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (5) , 2070-2075
A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy
Polymorphisms in the human endothelial nitric oxide synthase (eNOS) gene (NOS3) have been associated with advanced nephropathy in diabetic patients and with decreased expression in tissue culture. However, direct proof that modest genetic decreases in eNOS expression worsen diabetic nephropathy is lacking. To investigate this effect, we took advantage of the hybrid vigor and genetic uniformity of the F1 progeny (eNOS+/+, eNOS+/−, or eNOS−/− with or without diabetes) of a cross between heterozygous 129S6/SvEvTac eNOS+/− inbred females and heterozygous C57BL/6J eNOS+/− inbred males carrying the dominant Akita diabetogenic mutation Ins2C96Y/+. Whereas all C57BL/6J inbred eNOS−/− and eNOS+/− diabetic mice died before 5 mo, almost half of the F1 hybrid eNOS−/− and eNOS+/− diabetic mice lived until killed at 7 mo. Heterozygous eNOS+/− diabetic mice expressed ∼35% eNOS mRNA in the kidney and ∼25% glomerular eNOS protein relative to their eNOS+/+ diabetic littermates. These decreases in eNOS elevated blood pressure (BP) but not blood glucose. Urinary albumin excretion, mesangial expansion, glomerulosclerosis, mesangiolysis, and glomerular filtration rate increased in the order: eNOS+/+ Akita < eNOS+/− Akita < eNOS−/− Akita, independently of BP. Glomerular basement membrane thickening depended on increased BP. Renal expression of tissue factor and other inflammatory factors increased with the nephropathy; Nos2 also increased. Surprisingly, however, decreased eNOS expression ameliorated the increases in oxidative stress and tubulointerstitial fibrosis caused by diabetes. Our data demonstrate that a modest decrease in eNOS, comparable to that associated with human NOS3 variants, is sufficient to enhance diabetic nephropathy independently of its effects on BP.
- Open Access
- 1 January 2009
- Published by Oxford University Press (OUP) in NDT Plus
- Vol. 2 (Supplement) , ii1078
Experimental pathology - 1
- 1 January 2009
- Published by Oxford University Press (OUP) in NDT Plus
- Vol. 2 (Supplement) , ii1078
Open AccessExperimental pathology - 1
- 1 May 2005
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 6 (5) , 419-425
Many little things: one geneticist's view of complex diseases
Gene targeting is commonly used to knock out genes in order to understand their function. It has also been used successfully to model the relatively rare human genetic diseases that are caused by homozygous loss of gene function. Modelling the much more common multifactorial diseases that have strong genetic and environmental causes is less easy. Here, I describe my personal voyage into this challenging field, using gene targeting to alter the expression of genes that impact on hypertension and diabetes.
- 1 May 2005
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 6 (5) , 419-425
Many little things: one geneticist's view of complex diseases
Gene targeting is commonly used to knock out genes in order to understand their function. It has also been used successfully to model the relatively rare human genetic diseases that are caused by homozygous loss of gene function. Modelling the much more common multifactorial diseases that have strong genetic and environmental causes is less easy. Here, I describe my personal voyage into this challenging field, using gene targeting to alter the expression of genes that impact on hypertension and diabetes.
- 15 March 2002
- Published by Wiley in Microscopy Research and Technique
- Vol. 57 (1) , 55-59
Multiple roles of adrenomedullin revealed by animal models
The newly identified adrenomedullin (AM) gene codes for a potent, highly conserved vasodilator that is expressed in many tissues. Many biological functions have been ascribed to AM based on its broad expression pattern and numerous in vitro studies, and it is currently viewed as a multifunctional peptide hormone. Recent advances in gene manipulation have permitted the development of experimental animal systems to help distinguish between gene causes and effects in the context of otherwise normal physiology, and so the normal biological function of the AM gene can be studied within the intact physiological milieu of a whole animal. In this review article, we summarize the recent findings from three different types of genetic experiments involving the AM gene. Microsc. Res. Tech. 57:55–59, 2002.
- 15 March 2002
- Published by Wiley in Microscopy Research and Technique
- Vol. 57 (1) , 55-59
Multiple roles of adrenomedullin revealed by animal models
The newly identified adrenomedullin (AM) gene codes for a potent, highly conserved vasodilator that is expressed in many tissues. Many biological functions have been ascribed to AM based on its broad expression pattern and numerous in vitro studies, and it is currently viewed as a multifunctional peptide hormone. Recent advances in gene manipulation have permitted the development of experimental animal systems to help distinguish between gene causes and effects in the context of otherwise normal physiology, and so the normal biological function of the AM gene can be studied within the intact physiological milieu of a whole animal. In this review article, we summarize the recent findings from three different types of genetic experiments involving the AM gene. Microsc. Res. Tech. 57:55–59, 2002.
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 306
Interstitial Fibrosis in Chronic Hydronephrosis is Modulated by Angiotensinogen Expression • 1797
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 306
Interstitial Fibrosis in Chronic Hydronephrosis is Modulated by Angiotensinogen Expression • 1797